Compounding Pharmacy Due Diligence: A Checklist for Medical Practices
Choosing a compounding supplier is a compliance decision. Here is a complete due diligence checklist for medical practices evaluating compounding pharmacy partners.
Compounding Pharmacy Due Diligence: A Checklist for Medical Practices
Choosing a compounding supplier is not just a procurement decision β it is a compliance decision. The compounding pharmacy you work with becomes part of your compliance infrastructure. If they have problems, those problems can become your problems.
This checklist covers everything a medical practice should verify before establishing a relationship with a compounding supplier.
Licensing Verification
State Pharmacy License
- Verify the pharmacy holds a valid pharmacy license in its home state
- Confirm the license is current and in good standing (not suspended, revoked, or on probation)
- Check the license expiration date
How to verify: State board of pharmacy websites have license lookup tools. Search by pharmacy name or license number.
Non-Resident Pharmacy License (for out-of-state suppliers)
- Verify the pharmacy holds a non-resident pharmacy license in YOUR state
- Confirm the license is current and in good standing
- Verify the license covers the type of compounding you need (sterile, non-sterile, etc.)
Why this matters: A pharmacy that ships to your state without a non-resident license is operating illegally under your state's law. Products from an unlicensed source create significant liability.
503B FDA Registration (if applicable)
- If the supplier claims 503B status, verify FDA registration at fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Confirm the registration is current
- Check for any FDA enforcement actions against the facility
Quality Documentation
Certificate of Analysis (COA)
- Request a sample COA for a product you intend to order
- Verify the COA is from an independent third-party laboratory (not the compounder's own lab)
- Confirm the COA includes: identity testing, potency/assay, purity, endotoxin (for sterile preparations), and sterility (for sterile preparations)
- Verify the COA references the specific lot number
Stability Data
- Ask what BUD dates the supplier assigns to their products
- Request the stability data supporting those BUD dates
- Verify the stability data is from appropriate testing (not just USP defaults if claiming extended BUD dates)
Quality System Documentation
- Ask for a summary of their quality system
- Verify they have written SOPs for compounding, quality control, and release testing
- Ask about their out-of-specification (OOS) investigation process
Regulatory History
FDA Warning Letters
- Search the FDA warning letter database at fda.gov for the supplier's name
- Review any warning letters for the nature and severity of violations
- If warning letters exist, ask the supplier what corrective actions were taken
State Board Actions
- Check the supplier's home state board of pharmacy for any disciplinary actions
- Check your state's board for any actions against the supplier's non-resident license
Inspection History (503B facilities)
- Review FDA inspection records for 503B facilities (available at fda.gov)
- Check for any Form 483 observations (inspection findings)
- Assess the severity and resolution of any findings
Operational Capabilities
Licensing Coverage
- Confirm the supplier is licensed to ship to all states where your patients are located
- If you operate in multiple states, verify coverage for each
Product Availability
- Confirm the supplier carries the specific products you need
- Ask about typical lead times for in-stock items
- Ask about availability of custom formulations
Shipping Capabilities
- Confirm overnight shipping capability for temperature-sensitive products
- Ask about cold-chain packaging (cold packs, insulated containers)
- Ask about their process for handling shipping delays or temperature excursions
Order Minimums and Pricing
- Understand minimum order requirements
- Get pricing for your expected volume
- Understand pricing for custom orders
Communication and Support
Direct Access
- Can you reach a knowledgeable person directly (not just a call center)?
- Is 24/7 support available for urgent issues?
- Who is your primary contact for compliance questions?
Proactive Communication
- Will the supplier notify you proactively of regulatory changes affecting your supply?
- Will they notify you of supply issues before you run out?
- Do they have a process for communicating product recalls or quality issues?
Legal and Compliance Expertise
Regulatory Knowledge
- Does the supplier have legal or regulatory expertise on staff?
- Can they explain the regulatory basis for their compounding?
- Do they track FDA and state regulatory developments?
Mass-Tort and Litigation Background
- Has the supplier or its principals been involved in pharmaceutical litigation?
- Do they understand the litigation risk landscape for compounded medications?
Red Flags: When to Walk Away
Walk away from a supplier that:
- Cannot produce a COA on demand
- Cannot verify their state pharmacy license or FDA registration
- Has unresolved FDA warning letters
- Cannot explain the regulatory basis for their compounding
- Routes all communication through a call center with no direct access
- Offers prices that seem too good to be true
- Cannot confirm overnight shipping capability for temperature-sensitive products
MedClinic Partners Due Diligence
We welcome due diligence inquiries from prospective clients. We can provide:
- Licensing documentation for all relevant states
- Sample COAs
- Stability data summaries
- Regulatory history (clean record)
- Direct access to our team for compliance questions
Contact us to begin due diligence β
For licensed medical providers only. This checklist is for informational purposes and does not constitute legal advice.
Explore Topics
Written by
MedClinic Partners Editorial Team
B2B Medical Supply & Compounding Experts
The MedClinic Partners editorial team is composed of licensed medical operators, compounding compliance specialists, and mass-tort attorneys with direct experience running GLP-1 and peptide programs across all 50 states. Every article is reviewed for clinical accuracy, regulatory compliance, and practical applicability before publication.
Editorial standards: All content on medclinicpartners.com is reviewed by licensed medical operators and compounding compliance specialists before publication. Articles are updated when regulatory guidance changes. This content is for licensed healthcare providers only and does not constitute medical advice.